Home/Filings/4/0001209191-23-057975
4//SEC Filing

Yu Yong 4

Accession 0001209191-23-057975

CIK 0001231457other

Filed

Dec 7, 7:00 PM ET

Accepted

Dec 8, 5:57 PM ET

Size

5.1 KB

Accession

0001209191-23-057975

Insider Transaction Report

Form 4
Period: 2023-12-07
Yu Yong
VP, Clinical Trial Operations
Transactions
  • Sale

    Common Stock

    2023-12-07$11.85/sh36,800$435,99532,535 total
Footnotes (1)
  • [F1]The weighted average sale price for the transaction reported was $11.8477, and the range of prices were between $11.51 and $12.24. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

Issuer

GENELUX Corp

CIK 0001231457

Entity typeother

Related Parties

1
  • filerCIK 0001937482

Filing Metadata

Form type
4
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 5:57 PM ET
Size
5.1 KB